This article has been corrected to state that Roche's test detects 14 high-risk HPV types, rather than 13 as originally reported.

By a GenomeWeb staff reporter



NEW YORK (GenomeWeb News) – Roche today announced it has been awarded an exclusive contract by Karolinska University Hospital to provide its cobas HPV Test as a primary screening tool for human papillomavirus in women in Sweden.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.